Enrolling now · NCT06246799

A study testing whether a new weekly shot from The University of Texas Health Science Center at San Antonio, tirzepatide, can lower blood sugar and help with weight.

Who can join
Adults 18 to 75, have type 2 diabetes.
What you take
tirzepatide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
How long it lasts
The full study runs about 4.6 years; your own time in it is usually shorter.
What you get
The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Phase Phase 3Sponsor The University of Texas Health Science Center at San AntonioDrug tirzepatideClass GLP-1/GIPSites 2 USEnrollment target 256

What this study is for

Full study title: Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes.

Primary condition: Type 2 Diabetes (Adult Onset).

Who can join, in detail

Age 18 to 75
Sex All

Key inclusion criteria

  • Ability of subject to understand and the willingness to sign a written informed consent document.
  • Males and females; Age 18-75 years
  • Recently (within 5 years) diagnosed Type 2 Diabetes Mellitus (T2DM) patients
  • Drug naïve or receiving metformin monotherapy
  • HbA1c >6.5% (no limit on upper HbA1c value);

Key exclusion criteria

  • positive anti-GAD (antibodies to glutamic acid decarboxylase)
  • pregnancy or plan of becoming pregnant
  • evidence of proliferative diabetic retinopathy,
  • plasma creatinine >1.4 females or >1.5 males;
  • presence of congestive heart failure (CHF);

Where this study is enrolling

This trial has 2 US sites across 1 states. Contact the site coordinator directly to start the screening process.

Texas

  • University Health System Texas Diabetic Institute
    San Antonio, Texas
    Muhammad Abdul-Ghani, MD210-567-2391abdulghani@uthscsa.edu
  • UT Health Science Center
    San Antonio, Texas

Timeline

Started enrolling: 2024-11-07. Expected completion: 2029-06-30. Last updated on ClinicalTrials.gov: 2026-03-10.

Official source

We sync this data quarterly from ClinicalTrials.gov, the federal registry for clinical research. Before contacting a site, verify the trial is still recruiting on the official page:

View on ClinicalTrials.gov →

Back to the full directory → or take the matching quiz if you want clinical trials filtered to your conditions and location.

Why you can trust GLP ChartSame scoring framework applied to every program. No paid placements. No removal of unfavorable information at advertiser request. Pricing is pulled from each program's public-facing page weekly.